IP Library Granted Patent US 12,410,460
Granted Patent B2
US 12,410,460 · App. 17/285,631 · Granted Sep 9, 2025

Barcoding of nucleic acids

Inventors: Melinda Jasper (Collinswood, AU); Steven Myers (Glandore, AU)
Assignee: REVVITY HOLDINGS, INC.
C12Q1/6806C12N15/1006C12Q1/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,410,460
App. No.
17/285,631
Granted
Sep 9, 2025
Kind
B2
Abstract

The present disclosure relates to methods, kits and products for barcoding of nucleic acids. In certain embodiments, the present disclosure provides a method of producing nucleic acid for sequencing utilising clonal amplification on a solid substrate, the method comprising: (a) providing a nucleic acid sample for sequencing; (b) amplifying the nucleic acid sample using an amplifying primer comprising a degenerate nucleotide sequence and a 5′ fixed nucleotide sequence, to produce amplified nucleic acids; and (c) further amplifying the amplified nucleic acids with (i) a first primer comprising the 5′ fixed nucleotide sequence and a first adapter nucleotide sequence, and (ii) a second primer comprising the 5′ fixed nucleotide sequence and a second adapter nucleotide sequence, wherein the first adapter nucleotide sequence or the second adapter nucleotide sequence provides a sequence for subsequent priming of DNA synthesis from a nucleotide sequence attached to the solid substrate and the other adapter nucleotide sequence provides a sequence for subsequent priming of DNA synthesis from a template produced from the subsequent priming, and wherein one or more of the first primer, the second primer and the amplifying primer comprise a specific identifier sequence to identify nucleic acids amplified with the first primer, the second primer and/or the amplifying primer; thereby producing nucleic acid for sequencing utilising clonal amplification on the solid substrate.

Claims (24)

1. A method of producing nucleic acid for sequencing utilising clonal amplification on a solid substrate, the method comprising:

(a) providing a nucleic acid sample for sequencing;

(b) amplifying the nucleic acid sample using:

an amplifying primer comprising a degenerate nucleotide sequence and a 5′ fixed nucleotide sequence; and

one or more target specific primers,

to produce amplified nucleic acids; and

(c) further amplifying the amplified nucleic acids with (i) a first primer comprising the 5′ fixed nucleotide sequence and a first adapter nucleotide sequence, and (ii) a second primer comprising the 5′ fixed nucleotide sequence and a second adapter nucleotide sequence, wherein the first adapter nucleotide sequence or the second adapter nucleotide sequence provides a sequence for subsequent priming of DNA synthesis from a nucleotide sequence attached to the solid substrate and the other adapter nucleotide sequence provides a sequence for subsequent priming of DNA synthesis from a template produced from the subsequent priming, and wherein one or more of the first primer, the second primer and the amplifying primer comprise a specific identifier sequence to identify nucleic acids amplified with the first primer, the second primer and/or the amplifying primer;

thereby producing nucleic acid for sequencing utilising clonal amplification on the solid substrate.

2. The method according to claim 1 , wherein the amplifying primer comprises a degenerate nucleotide sequence consisting of 6 nucleotides.

3. The method according to claim 1 , wherein the amplifying primer comprises a fixed nucleotide sequence 3′ to the degenerate nucleotide sequence.

4. The method according to claim 3 , wherein the fixed nucleotide sequence 3′ to the degenerate nucleotide sequence consists of a nucleotide sequence of 6 nucleotides.

5. The method according to claim 3 , wherein the fixed nucleotide sequence 3′ to the degenerate nucleotide sequence consists of the nucleotide sequence 5′-ATGTGG-, 5′-ATCTCA-3′ or TGAGAT.

6. The method according to claim 1 , wherein the 5′ fixed nucleotide sequence consists of a nucleotide sequence of 10 nucleotides.

7. The method according to claim 1 , wherein the 5′ fixed nucleotide sequence consists of the nucleotide sequence 5′-CCAGCCTTGC-3′ (SEQ ID NO: 2), 5′-CCGACTCGAG-3′ (SEQ ID NO: 23), 5′-GATGCTCGAG-3′ (SEQ ID NO: 24), 5′-GATGCCTTGC-3′ (SEQ ID NO: 25), 5′-GCTCTTCCGATCT-3′ (SEQ ID NO: 26), 5′-GCTCTTCCGATCTACTCGAG-3′ (SEQ ID NO: 27), 5′-GCTCTTCCGATCTGAG-3′ (SEQ ID NO: 18), 5′-AGTTCAGACGTGTGCTCTTCCGATCT-3′ (SEQ ID NO: 28) or 5′-CAGACGTGTGCTCTTCCGATCT-3′ (SEQ ID NO: 29).

8. The method according to claim 1 , wherein the first adapter nucleotide sequence comprises the nucleotide sequence 5′-CCGCTTTCCTCTCTATGGGCAGTCGGTGAT-3′ (SEQ ID NO: 11) or 5′-CCTCTCTATGGGCAGTCGGTGAT-3′ (SEQ ID NO: 47).

9. The method according to claim 1 , wherein the second adapter nucleotide sequence comprises the nucleotide sequence 5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-3′ (SEQ ID NO: 14).

10. The method according to claim 1 , wherein the first primer comprises a first adapter nucleotide sequence for subsequent priming of DNA synthesis and the second primer comprises a second adapter sequence which is identical or complementary to a nucleotide sequence attached to the solid substrate.

11. The method according to claim 1 , wherein the first primer and the second primer comprise a nucleotide sequence which is identical or complementary to a nucleotide sequence attached to the solid substrate.

12. The method according to claim 1 , wherein the specific identifier sequence consists of a nucleotide sequence of 10 nucleotides.

13. The method according to claim 1 , wherein the specific identifier sequence comprises the nucleotide sequence 5′-TCTAACGGAC-3 (SEQ ID NO: 3).

14. The method according to claim 1 , wherein the amplifying primer comprises a specific identifier sequence, the first primer comprises a first adapter sequence for subsequent priming of DNA synthesis, and the second primer comprises a nucleotide sequence identical or complementary to a nucleotide sequence attached to the solid substrate and a specific identifier sequence.

15. The method according to claim 1 , wherein the first primer comprises a first adapter sequence for subsequent priming of DNA synthesis and a specific identifier sequence, and the second primer comprises a nucleotide sequence identical or complementary to a nucleotide sequence attached to the solid substrate.

16. The method according to claim 1 , wherein the first primer comprises a first adapter sequence for subsequent priming of DNA synthesis and a nucleotide sequence identical or complementary to a nucleotide sequence attached to the solid substrate, and the second primer comprises a nucleotide sequence identical or complementary to another nucleotide sequence attached to the solid substrate and a specific identifier sequence.

17. The method according to claim 1 , wherein the method further comprises further amplifying with the one or more target specific primers in step (c).

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2024
From: MYERS, STEVEN
To: PERKINELMER HEALTH SCIENCES (AUSTRALIA) PTY LTD.
Reel/Frame 069641/0811 →
EMPLOYMENT AGREEMENT COVERING DATE OF PATENT APPLICATION FILING, IN WHICH ASSIGNOR WAS EMPLOYED BY ASSIGNEE, INCLUDING LANGUAGE, ACCEPTED BY THE ASSIGNOR, ASSIGNING TO ASSIGNEE ALL INVENTIONS MADE BY ASSIGNOR WHILE EMPLOYED BY ASSIGNEE. Recorded Dec 19, 2024
From: JASPER, MELINDA
To: PERKINELMER HEALTH SCIENCES (AUSTRALIA) PTY LTD.
Reel/Frame 069941/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2024
From: PERKINELMER GLOBAL HOLDINGS S.À R.L.
To: PERKINELMER HOLDINGS, INC.
Reel/Frame 066525/0244 →
CHANGE OF NAME Recorded Feb 22, 2024
From: PERKINELMER HOLDINGS, INC.
To: REVVITY HOLDINGS, INC.
Reel/Frame 066646/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2024
From: PERKINELMER HEALTH SCIENCES, (AUSTRALIA) PTY LTD
To: PERKINELMER DIAGNOSTICS GLOBAL HOLDINGS S.À R.L.
Reel/Frame 066517/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2024
From: PERKINELMER DIAGNOSTICS GLOBAL HOLDINGS S.À R.L.
To: PERKINELMER GLOBAL HOLDINGS S.À R.L.
Reel/Frame 066517/0986 →
Priority Claims (1)
AU 2018903923 · Oct 17, 2018 · national
Continuity (1)
Related Publication 20210381027A1 · Dec 9, 2021
References Cited (35)
US 5994058A · Senapathy · 1999 [cited by applicant]
US 6365375B1 · Dietmaier · 2002 [cited by applicant]
US 9249459B2 · Hamilton et al. · 2016 [cited by applicant]
US 20100184152A1 · Sandler et al. · 2010 [cited by applicant]
US 20110033862A1 · Rabinowitz et al. · 2011 [cited by applicant]
US 20140017683A1 · Yin · 2014 [cited by examiner]
US 20200248264A1 · Rabinowitz · 2020 [cited by examiner]
CN 107699957A · 2018 [cited by applicant]
EP 2660331A1 · 2013 [cited by applicant]
EP 2770090B1 · 2018 [cited by examiner]
WO WO2009105531A1 · 2009 [cited by applicant]
WO WO2011131192A1 · 2011 [cited by applicant]
WO WO2016010856A1 · 2016 [cited by applicant]
WO WO2017165925A1 · 2017 [cited by applicant]
McClenahan et al, Optimization of virus detection in cells using massively parallel sequencing, Biologicals. Jan. 2014;42(1):34-41. doi: 10.1016/j.biologicals.2013.11.002. Epub Dec. 3, 2013. [cited by examiner]
Roche, KAPA Adapter Kits Ion Torrent™ Platforms, KR0574—v3.16, Oct. 2016. [cited by examiner]
GenBank Accession No. HO910453, published Oct. 25, 2010 (1 page). [cited by applicant]
International Search Report PCT/AU2019/051121, dated Dec. 28, 2019 (7 pages). [cited by applicant]
McClenahan et al., “Optimizaton of virus detection in cells using massively parallel sequencing,” Biologicals, vol. 42(1): 34-41 (2014). [cited by applicant]
China P10136-PI.210702 First Office Action, Jul. 2, 2021 (5 pages). [cited by applicant]
Chinese Patent Application No. 201780033969.0 (translation), Applicant: PerkinElmer Health Sciences (Australia) Pty Ltd, Text of First Office Action titled Amplification of Target Sequences, POF Ref. FF56185/18 (3 pages… [cited by applicant]
Cheung, Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA, PNAS, vol. 93(25): 14676-14679 (1996). [cited by applicant]
EPO Communication Pursuant to Article 94(3), Application No. 17 772 883.9-1118, dated Jun. 16, 2021 (9 pages). [cited by applicant]
India First Examination Report, Application No. 201837040731 dated Mar. 22, 2021 (6 pages). [cited by applicant]
India Hearing Notice dated Jan. 28, 2022, POK/Application No. 201837040731 (3 pages). [cited by applicant]
Lorenz, Polymerase Chain Reaction: Basic Protocol Plus Troubleshooting and Optimization Strategies, J. Vis. Exp. vol. 63: e3998 (2012). (2012). [cited by applicant]
Martino et al., “Novel degenerate PCR method for whole-genome amplification applied to Peru Margin (ODP Leg 201) subsurface samples,” Frontiers in Microbiology, vol. 3(17): 1-11 (2012). [cited by applicant]
Nakayama et al., “Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction,” Med Sci monit, vol. 7(3): 345-349 (2001). [cited by applicant]
Pich, Utility of DNA amplified by degenerate oligonucleotide-primed PCT (DOP-PCR) from the total genome and defined chromosomal regions of field bean, Mol. Gen. Genet. vol. 243: 173-177 (1994). [cited by applicant]
Telenius et al., “Degenerate Oligonucleotide-Primed PCR: General Amplification of Targe DNA by a Single Degenerate Primer,” Genomics, vol. 13: 178-725 (1992). [cited by applicant]
Supplementary European Search Report EP 19 87 3852, dated Jun. 14, 2022 (3 pages). [cited by applicant]
Wang et al., “Fusion primer and nested integrated PCR (FPNI-PCR): a new high-efficiency strategy for rapid chromosome walking or flanking sequence cloning,” BMC Biotechnology, vol. 11(109) 12 pages (2011). [cited by applicant]
Ferrarini et al., “A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCT whole-genome amplification products,” PLOS One, vol. 13(3): e0193689: 1-24 (2018). [cited by applicant]
Kitson et al., “Detecting host-parasitoid interactions in an invasive Lepidopteran using nested tagging DNA-metabarcoding,” Internet <https://doi.org/10.1101/035071>, Jan. 2019. [cited by applicant]
Miya et al., “MIFish, a set of universal PCR primers for metabarcoding environmental DNA from fishes: detection of more than 230 subtropical marine species,” The Royal Society Open Science, vol. 2:150088: 1-33 (2015). [cited by applicant]